REG - BkofA Merrill Lynch - Grifols - Post-Stabilisation Notice

Grifols SAAnnouncement

01/10/2021 09:45

RNS Number : 7117N
  
Bank of America Merrill Lynch
  
01 October 2021
  
 

30 September 2021
 
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
 
Grifols Escrow Issuer, S.A.U.
 
Post-stabilisation Period Announcement
 
 
Further to the pre-stabilisation period announcement dated 28 September 2021 BofASE (contact: Murad Khaled; telephone: +442079953092) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager named below in relation to the offer of the following securities.
 



Issuer:


Grifols Escrow Issuer, S.A.U.




Guarantor (if any):


Grifols S.A. (Spain), Grifols Worldwide Operations Limited (Ireland), Grifols International S.A. (Spain), Grifols Shared Services North America, Inc. (USA), Instituto Grifols S.A. (Spain), Grifols Worldwide Operation USA, Inc., Grifols USA, LLC (USA), Grifols Biologicals LLC (USA), Grifols Therapeutics LLC (USA)




Aggregate nominal amount:


€1,400,000,000 




Description:


€1,400,000,000 3.875% Senior Notes due 2028




Stabilisation Manager(s):


Bank of America Securities Europe S.A.




Offer price:


100.000%



 
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
STAFIFVDIRLLIIL